32 unchanged sentences
Pain and Spine Specialists of Maryland, LLC;
−Removed: SimCare ASC, LLC initiated a lawsuit against the Company and others in the United States District Court for the District of Maryland
−Removed: (the “2022 Lawsuit”).
−Removed: The plaintiffs in this lawsuit are business entities owned or partially owned by the plaintiffs that initiated
−Removed: the litigation described above.
−Removed: The Complaint asserted claims under the RICO Act, as well as fraudulent misrepresentation,
−Removed: intentional misrepresentation by concealment, and civil conspiracy and seeks compensatory damages in excess of $75,000, pre-judgment
−Removed: interest, punitive damages, attorney’s fees, and court costs.
−Removed: The Complaint states that the Company, distributors of the
−Removed: Company’s product, and medical billing and coding consultants allegedly made misrepresentations to the plaintiffs that the
−Removed: Company’s NeuroStim device and related procedures could be billed to, and reimbursed by, Medicare and other insurance payors
−Removed: as a surgically implantable neurostimulator.
−Removed: Plaintiffs claim to have suffered damages when Medicare administrative contractors
−Removed: declined to pay plaintiffs for their use of the device.
+Added: ASC, LLC initiated a lawsuit against the Company and others in the United States District Court for the District of Maryland (the “2022
+Added: The plaintiffs in this lawsuit are business entities owned or partially owned by the plaintiffs that initiated the litigation
+Added: described above.
+Added: The Complaint asserted claims under the RICO Act, as well as fraudulent misrepresentation, intentional misrepresentation
+Added: by concealment, and civil conspiracy and seeks compensatory damages in excess of $75,000, pre-judgment interest, punitive damages, attorney’s
+Added: fees, and court costs.
+Added: The Complaint states that the Company, distributors of the Company’s product, and medical billing and coding
+Added: consultants allegedly made misrepresentations to the plaintiffs that the Company’s NeuroStim device and related procedures could
+Added: be billed to, and reimbursed by, Medicare and other insurance payors as a surgically implantable neurostimulator.
+Added: Plaintiffs claim to
+Added: have suffered damages when Medicare administrative contractors declined to pay plaintiffs for their use of the device.
September 28, 2022, the Company filed a motion to dismiss all claims.
5 unchanged sentences
disputes in both cases through an independent third-party mediator.
−Removed: On April 25, 2025, the parties reached a
−Removed: tentative $750,000 settlement payable in 12 equal monthly installments beginning in January of 2026.
+Added: May 15, 2025, the parties executed a $750,000 settlement agreement payable in 12 equal monthly installments beginning in January of 2026.
January 2024, Dr.
3 unchanged sentences
The Company denied both the neurostimulation patent and compensation claims.
−Removed: The case remains unresolved.
−Removed: While it is too early to predict the ultimate outcome of this matter, we believe the Company
−Removed: has meritorious defenses and intends to defend this matter vigorously.
+Added: The case remains
+Added: While it is too early to predict the ultimate outcome of this matter, we believe the Company has meritorious defenses and
+Added: intends to defend this matter vigorously.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.